Authors:
Floridia, M
Tomino, C
Bucciardini, R
Ricciardulli, D
Fragola, V
Pirillo, MF
Amici, R
Giannini, G
Galluzzo, CM
Andreotti, M
Seeber, AC
Ammassari, A
Cingolani, A
Lazzarin, A
Scalise, G
Cargnel, A
Suter, F
Milazzo, F
Pastore, G
Moroni, M
Ciammarughi, R
Pini, R
Carosi, G
D'Amato, C
Contu, L
Concia, E
Bonazzi, L
Aiuti, F
Vigevani, G
Vella, S
Citation: M. Floridia et al., A randomized trial comparing the introduction of ritonavir or indinavir in1251 nucleoside-experienced patients with advanced HIV infection, AIDS RES H, 16(17), 2000, pp. 1809-1820
Authors:
Mussini, C
Pezzotti, P
Govoni, A
Borghi, V
Antinori, A
Monforte, AD
De Luca, A
Mongiardo, N
Cerri, MC
Chiodo, F
Concia, E
Bonazzi, L
Moroni, M
Ortona, L
Esposito, R
Cossarizza, A
De Rienzo, B
Citation: C. Mussini et al., Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: The changes in opportunistic prophylaxis study, J INFEC DIS, 181(5), 2000, pp. 1635-1642
Authors:
Matteelli, A
Olliaro, P
Signorini, L
Cadeo, G
Scalzini, A
Bonazzi, L
Caligaris, S
Tomasoni, L
Tebaldi, A
Carosi, G
Citation: A. Matteelli et al., Tolerability of twice-weekly rifabutin-isoniazid combinations versus dailyisoniazid for latent tuberculosis in HIV-infected subjects: a pilot study, INT J TUBE, 3(11), 1999, pp. 1043-1046